Connect with us

News

CSIR-NAL Develops Non-Invasive Ventilator To Treat COVID-19 Patients

According to Jitendra J Jadhav, Director CSIR-NAL, non-invasive ventilator will be ideal to treat moderate or mid-stage severe COVID-19 patients who do not require intubation and invasive ventilation

CSIR-NAL Develops Non-Invasive Ventilator To Treat COVID-19 Patients
Highlights
  • CSIR-NAL has developed non-invasive BiPAP Ventilator 'SwasthVayu'
  • Ventilator to treat COVID-19 patients has been developed in 36 days
  • Ventilator has been certified for safety and performance by NABL

New Delhi: In a record time of just 36 days a non-invasive BiPAP Ventilator ‘SwasthVayu’ has been developed by CSIR – National Aerospace Laboratories (NAL), Bangalore, a constituent of lab of CSIR to treat COVID-19 patients. Dr Shekhar C Mande, DG CSIR said that CSIR NAL team has enabled a spin-off technology based on its expertise in the aerospace design domain. The system has undergone stringent biomedical tests and beta clinical trials at NAL Health Centre.

Jitendra J Jadhav, Director CSIR-NAL said the non-invasive ventilator will be ideal to treat moderate or mid-stage severe COVID-19 patients who do not require intubation and invasive ventilation.

Based on global experience and specific inputs from pulmonologists in India and abroad, CSIR-NAL developed BIPAP non-invasive ventilator with externally connected oxygen concentrator which will be ideal to treat moderate or mid-stage severe COVID-19 patients who do not require intubation and invasive ventilation, he said.

Also Read: Fighting COVID19: Health Ministry To Conduct Population-Based Sero Survey In Select Districts

The system has been certified for safety and performance by National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited agencies and undergone stringent biomedical tests.

Officials said that the major advantage of this machine is that it does not require any specialised nursing for usage. They said it is cost effective, compact and configured with majority of indigenous components and is ideal for treating COVID -19 patients in wards, makeshift hospitals, dispensaries and homes in current Indian COVID-19 scenario.

It’s unique features like spontaneous, CPAP, timed, auto BIPAP modes with provision to connect Oxygen concentrator or enrichment unit externally alleviate the fear of the virus spread.

BiPAP non-invasive ventilator is a microcontroller-based precise closed-loop adaptive control system with a built-in biocompatible “3D printed manifold and coupler” with HEPA filter (Highly Efficient Particulate Air Filter).

CSIR-NAL is in process of taking it forward with the regulatory authorities for the approval and expected to get permission shortly. It has already initiated dialogue with major public/private industries to partner for mass production.

Also Read: Stanford, IIT alumni Develop ‘Intelligent Robot’ For Chemical-Free Disinfection Of Public Places

Highlights Of The 12-Hour Telethon

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पड़े

Folk Music For A Swasth India

RajasthanDay” src=